CRISPR Therapeutics AG CRSP
NASDAQ CRSP
$45.75 +0.60 (+1.33%)
As of: Nov 11, 2026 · 3:59 PM EST

CRISPR Therapeutics AG (CRSP) Return on Capital Employed [ROCE] (2016 - 2026)

Updated

CRISPR Therapeutics AG's Return on Capital Employed [ROCE] came in at -21.62% for Q3 2026, up 6.84 percentage points from -28.46% a year earlier but down 0.71 percentage points from the prior quarter.

Analysis

CRISPR Therapeutics AG (CRSP) Return on Capital Employed [ROCE] (2016 - 2026) Analysis & Trends

For FY2025, CRISPR Therapeutics AG's Return on Capital Employed [ROCE] was -31.58%, down 9.86 percentage points from FY2024.

  • Return on Capital Employed [ROCE] carries a five-year change of -5.38 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Capital Employed [ROCE] was -21.72% in FY2024 (-11.26 pp), -10.46% in FY2023 (+17.87 pp), -28.33% in FY2022 (-45.54 pp) and 17.21% in FY2021 (+43.41 pp).
  • The five-year range for quarterly Return on Capital Employed [ROCE] is -31.55% (Q4 2025) to 14.01% (Q4 2021).
  • Year-over-year, Return on Capital Employed [ROCE] increased in two of the last eight quarters, with an average year-over-year change of -5.80 percentage points.
  • The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q4 2021 (a gain of 36.69 percentage points), and the weakest in Q2 2022 (a drop of 45.48 percentage points).
  • Business Quant data shows CRSP's Return on Capital Employed [ROCE] at -20.91% (Q2 2026), -27.40% (Q1 2026) and -31.55% (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 CRISPR Therapeutics AG 4.37 Bn -4.68 Bn - -21.62%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -21.62%
Jun 30, 2026 -20.91%
Mar 31, 2026 -27.40%
Dec 31, 2025 -31.55%
Sep 30, 2025 -28.46%
Jun 30, 2025 -27.71%
Mar 31, 2025 -22.76%
Dec 31, 2024 -21.59%
Sep 30, 2024 -15.05%
Jun 30, 2024 -15.68%
Mar 31, 2024 -13.48%
Dec 31, 2023 -10.86%
Sep 30, 2023 -20.86%
Jun 30, 2023 -22.69%
Mar 31, 2023 -26.79%
Dec 31, 2022 -30.92%
Sep 30, 2022 -30.45%
Jun 30, 2022 -26.25%
Mar 31, 2022 12.17%
Dec 31, 2021 14.01%
API Access

CRISPR Therapeutics AG Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CRSP&period=max&api_key=YOUR_API_KEY